Thermo Fisher Scientific (China) and Luca Healthcare announce a strategic collaboration to explore developing a digital patient assistant and digital medication adherence solutions to support direct-to-patient clinical trial services in China

06 Nov, 2021

Shanghai, November 6, 2021 – Thermo Fisher Scientific (China), the world leader in serving science, with a mission to enable customers to make the world healthier, cleaner and safer, and Luca Healthcare, China’s category leader in clinically validated, software-based screening, treatment and patient management tools, today at the 4th China International Import Expo (“CIIE”) announced a strategic collaboration to explore developing a digital patient assistant data platform and digital medication adherence solutions to support direct-to-patient clinical trial services in China.

“We look forward to working with Luca Healthcare to add digital solutions to our clinical service offerings, particularly as we continue to enhance our capabilities to support a more patient-centric model for clinical trial services,” said Mr. Hann Pang, President of Thermo Fisher Scientific China.

“We are excited to partner with Thermo Fisher Scientific to look for ways to integrate with existing DTP drug home delivery services, mobile nurse, and at-home patient data collection capabilities through a single digital patient assistant and provide study sponsors with visibility, communication, and full access to trial patients,” said Echo Chen, Ph.D., Chief Executive Officer of Luca Healthcare. “Luca Healthcare’s broad portfolio of out-of-hospital digital tools can assist sponsors in non-traditional study sites. With the rapid emergence of decentralized clinical trials, we look forward to working with clinical trial services providers and CROs to facilitate both virtual and hybrid clinical trials.”

About Luca Healthcare

Luca Healthcare is a leader in using AI algorithms and machine learning to develop predictive healthcare solutions. We build innovative software solutions that analyze behavioral and physiological characteristics associated with diseases across a wide range of therapeutic areas. The company’s digital solutions improve patient outcomes through disease diagnosis and identifying shifts in disease progression or exacerbations that require proactive interventions. Backed by scientific evidence and clinical validation, our platform delivers significant value to patients, providers and life sciences companies.

About Thermo Fisher Scientific (China)

Thermo Fisher Scientific (China) Co., Ltd has been operating in China for over 35 years. Headquartered in Shanghai, Thermo Fisher Scientific China has branch offices in Beijing, Guangzhou, Hong Kong, Chengdu, Shenyang, Xi’an, Nanjing, Wuhan, Jinan, and Dongguan with around 5,000 employees. Our products mainly include analytical instruments, laboratory equipment, chemical reagents, consumables, software and more; providing comprehensive laboratory solutions and serving customers across various industries. In order to meet the local needs in China, we have established 8 manufacturing sites and 6 application centers and demo labs across the country which bring world-class technology and products with application development and training services to local customers. We have a nationwide maintenance network and China service training team, including over 2,800 professionals directly providing services for customers. We are committed to enabling our customers to make the world healthier, cleaner and safer.